What is the correct storage for Orofer (ferric carboxymaltose) and what should be done after it was kept in a refrigerator for three days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Storage Requirements for Orofer (Ferric Carboxymaltose) and Management After Refrigeration

The medication should be discarded after being refrigerated for 3 days, as ferric carboxymaltose must never be frozen or stored below its specified temperature range of 8-25°C, and refrigeration at 2-8°C falls below the minimum storage temperature, potentially compromising drug stability and safety.

Correct Storage Parameters

Orofer (ferric carboxymaltose) must be stored at 8-25°C (46-77°F) and should never be refrigerated or frozen. 1, 2, 3 This temperature range is critical for maintaining the molecular structure and therapeutic efficacy of the iron formulation.

  • The label explicitly states "do not refrigerate" because temperatures below 8°C can alter the drug's stability and potentially cause precipitation or molecular changes 1, 2
  • Storage should occur in a cool, dry place protected from direct sunlight, heat sources, and excessive agitation 4, 1
  • The medication should be kept at ambient room temperature (15-30°C is acceptable, though 8-25°C is the labeled range) away from temperature extremes 1, 3

Why the Pharmacy Error Occurred

The pharmacy incorrectly provided an ice pack, likely confusing ferric carboxymaltose storage requirements with other injectable medications that require refrigeration at 2-8°C (such as certain biologics or insulin) 2, 3. This represents a significant dispensing error.

What Happens When Stored Below 8°C

  • Temperatures below the minimum threshold of 8°C can cause loss of potency, clumping, frosting, or precipitation in iron formulations 1, 3
  • Exposure to refrigeration temperatures (2-8°C) for 3 days represents a significant temperature excursion outside the acceptable range 1, 2
  • Visual inspection may not reliably detect all forms of degradation, as molecular changes can occur without obvious physical signs 1, 3

Recommended Action

Discard the medication and obtain a replacement vial stored correctly at 8-25°C. 1, 2

  • Do not administer the refrigerated medication, even if it appears visually normal, because temperature-induced degradation may not be visible 1, 3
  • Contact the pharmacy immediately to report the storage error and request proper replacement at no cost to the patient, as this was a pharmacy dispensing error 2
  • Document the incident, including the lot number and dates of refrigeration, for quality assurance purposes 4

Visual Inspection Criteria (For Future Reference)

Before any administration of ferric carboxymaltose, always inspect for: 1, 2, 3

  • Clumping or aggregation of particles
  • Frosting or crystallization
  • Precipitation or sediment
  • Changes in clarity or color from the expected appearance
  • Any of these findings mandate immediate disposal

Preventing Future Errors

  • Verify storage requirements directly from the product label before accepting medication from the pharmacy 4, 2
  • Educate the patient that ferric carboxymaltose should be stored at room temperature (8-25°C), not refrigerated 1, 3
  • If transporting the medication, use insulated bags only in extreme heat (>25°C) to prevent overheating, never to keep it cold 1, 2
  • Confirm with the pharmacy that they understand the "do not refrigerate" requirement for future dispensing 4, 2

Common Pitfall to Avoid

Never attempt to "salvage" improperly stored ferric carboxymaltose by warming it to room temperature. 1, 2 Once exposed to temperatures outside the 8-25°C range for an extended period (3 days in this case), the medication's integrity cannot be guaranteed and it must be replaced, not rewarmed and used.

References

Guideline

Retatrutide Injection Temperature and Storage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Storage and Handling of IV Co-Amoxiclav

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Storage and Handling Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What were the efficacy outcomes for the FAIR-HF trial in iron-deficient heart failure patients treated with intravenous ferric carboxymaltose (Iron deficiency, New York Heart Association (NYHA) Functional Class)?
What is the proper use of Ferinject (ferric carboxymaltose) for iron deficiency?
What are the details of the FAIR-HF (Ferinject Assessment in Patients with Iron Deficiency and Chronic Heart Failure) and CONFIRM-HF (Ferric Carboxymaltose Evaluation on Performance in Patients with Iron Deficiency in Chronic Heart Failure) trials on intravenous iron supplementation with ferric carboxymaltose in patients with heart failure and iron deficiency?
Can IV (intravenous) ferric carboxymaltose (iron) and oral iron be given simultaneously?
Can oral iron be used as a first line treatment for patients with hyperferritinemia and low Transferrin Saturation (TSAT)?
When is it safe to start long‑acting insulin glargine in a septic patient with hyperglycemia, and what initial dose is recommended?
What are the benefits and recommended dosing of L‑carnitine in end‑stage renal disease patients on chronic hemodialysis with functional carnitine deficiency?
What is the WHO‑recommended vitamin A dosing regimen for a child with measles, including doses for different age groups?
What is the recommended daily vitamin A intake and safe upper limit for adults, and what dosing regimen should be used to treat vitamin A deficiency?
What dose of intravenous magnesium sulfate should be given to an adult with a QTc of 603 ms?
What dose of intravenous magnesium sulfate should be given to an adult with a corrected QT interval of 603 ms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.